Capstone Investment Advisors
ETNB

Capstone Investment Advisors’s 89bio ETNB Stock Holding History

Capstone Investment Advisors’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,900
Closed -$190K – 1742
2025
Q3 		$190K Buy
+12,900
New +$131K ﹤0.01% 1843
2024
Q2 		– Sell
-103,767
Closed -$1.21M – 2191
2024
Q1 		$1.21M Buy
+103,767
New +$1.15M ﹤0.01% 1032

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Capstone Investment Advisors's ETNB Position: Q4 2025 in Review

Capstone Investment Advisors sold out of 89bio (ETNB) in Q4 2025, closing a stake of 12,900 shares — an estimated $190K sold.

Capstone Investment Advisors first reported a position in ETNB in Q1 2024 and held it in 2 quarters. The position peaked at $1.21M in Q1 2024. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Capstone Investment Advisors reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 12,900 89bio shares in Q4 2025, an estimated $190K.
  • Capstone Investment Advisors first reported a position in 89bio in Q1 2024 and held it in 2 quarters.
  • Capstone Investment Advisors's 89bio position peaked at $1.21M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Capstone Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.